Department of Microbiology and Immunology, H. M. Bligh Cancer Research Laboratories, Rosalind Franklin University of Medicine and Science, Chicago Medical School, 3333 Green Bay Road, North Chicago, IL 60064, USA.
J Gen Virol. 2012 Feb;93(Pt 2):235-246. doi: 10.1099/vir.0.034033-0. Epub 2011 Oct 12.
Interleukin-1β (IL-1β) is a potent pro-inflammatory cytokine involved in the pathogenesis of HCV, but the sensors and underlying mechanisms that facilitate HCV-induced IL-1β proteolytic activation and secretion remains unclear. In this study, we have identified a signalling pathway leading to IL-1β activation and secretion in response to HCV infection. Previous studies have shown the induction and secretion of IL-1β through the inflammasome complex in macrophages/monocytes. Here, we report for the first time the induction and assembly of the NALP3-inflammasome complex in human hepatoma cells infected with HCV (JFH-1). We demonstrate that activation of IL-1β in HCV-infected cells involves the proteolytic processing of pro-caspase-1 into mature caspase-1 in a multiprotein inflammasome complex. Next, we demonstrate that HCV is sensed by NALP3 protein, which recruits the adaptor protein ASC for the assembly of the inflammasome complex. Using a small interfering RNA approach, we further show that components of the inflammasome complex are involved in the activation of IL-1β in HCV-infected cells. Our study also demonstrates the role of reactive oxygen species in HCV-induced IL-1β secretion. Collectively, these observations provide an insight into the mechanism of IL-1β processing and secretion, which is likely to provide novel strategies for targeting the viral or cellular determinants to arrest the progression of liver disease associated with chronic HCV infection.
白细胞介素-1β(IL-1β)是一种有效的促炎细胞因子,参与丙型肝炎病毒(HCV)的发病机制,但促进 HCV 诱导的 IL-1β蛋白水解激活和分泌的传感器和潜在机制仍不清楚。在这项研究中,我们已经确定了一条信号通路,该通路可导致 HCV 感染后 IL-1β的激活和分泌。先前的研究表明,巨噬细胞/单核细胞中的炎性小体复合物可诱导和分泌 IL-1β。在这里,我们首次报道了 HCV(JFH-1)感染的人肝癌细胞中 NALP3-炎性小体复合物的诱导和组装。我们证明,HCV 感染细胞中 IL-1β的激活涉及前胱天蛋白酶-1在多蛋白炎性小体复合物中的蛋白水解加工为成熟的胱天蛋白酶-1。接下来,我们证明 HCV 被 NALP3 蛋白识别,该蛋白募集衔接蛋白 ASC 用于炎性小体复合物的组装。使用小干扰 RNA 方法,我们进一步表明炎性小体复合物的成分参与了 HCV 感染细胞中 IL-1β的激活。我们的研究还表明活性氧在 HCV 诱导的 IL-1β分泌中的作用。总之,这些观察结果提供了对 IL-1β加工和分泌机制的深入了解,这可能为针对病毒或细胞决定因素以阻止与慢性 HCV 感染相关的肝病进展提供新的策略。
J Gen Virol. 2011-10-12
PLoS Pathog. 2017-1-6
Front Cell Infect Microbiol. 2024
Front Cell Infect Microbiol. 2023
Front Pharmacol. 2022-10-31
Drug Metab Dispos. 2022-5
Medicina (Kaunas). 2022-1-13
Nat Rev Immunol. 2010-9-17
Nat Immunol. 2010-4-11
Cell Cycle. 2009-7-1